These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36788942)

  • 1. The diagnostic and prognostic value of growth differentiation factor-15 in systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Qian J; Ding Y; Yang X; Wang Q; Zhao J; Liu Y; Tian Z; Wang Y; Li M; Zeng X
    Pulm Circ; 2023 Jan; 13(1):e12195. PubMed ID: 36788942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye signs as a novel risk predictor in pulmonary arterial hypertension associated with systemic lupus erythematosus.
    Li J; Xiong J; Liu P; Peng Y; Cai S; Fang X; Yu S; Zhao J; Wu R
    Adv Rheumatol; 2024 Feb; 64(1):15. PubMed ID: 38424650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension.
    Rhodes CJ; Wharton J; Howard LS; Gibbs JS; Wilkins MR
    Heart; 2011 Jul; 97(13):1054-60. PubMed ID: 21558476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine-rich protein 61 as a novel biomarker in systemic lupus erythematosus-associated pulmonary arterial hypertension.
    Fan Y; Zhao J; Qian J; Hao Y; Wang Q; Gao L; Li M; Zeng X; Zhang Z
    Clin Exp Rheumatol; 2019; 37(4):623-632. PubMed ID: 30620287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
    Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular-pulmonary arterial coupling ratio derived from 3-dimensional echocardiography predicts outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension patients.
    Lan WF; Deng Y; Dai P; Wu DD; Hu J; Liao J; Meng H
    Lupus; 2024 Feb; 33(2):155-165. PubMed ID: 38182135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of heart rate recovery in female patients with pulmonary arterial hypertension due to systemic lupus erythematosus.
    Yang GL; Guo J; Pudasaini B; Yuan P; Gong SG; Wang L; Zhao QH; Yang WL; Jiang R; Zhou C; Liu JM
    Clin Respir J; 2019 Sep; 13(9):545-554. PubMed ID: 31295761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension.
    Meadows CA; Risbano MG; Zhang L; Geraci MW; Tuder RM; Collier DH; Bull TM
    Chest; 2011 May; 139(5):994-1002. PubMed ID: 20829333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review.
    Li M; Tian Z; Qian J; Huang C; Zhao J; Wang Q; Song Y; Tian X; Li M; Liu J; Zeng X
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35256456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
    Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
    Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet Distribution Width Level in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension and Its Diagnostic Value.
    He Y; Yu Y; Hu S
    Arch Rheumatol; 2020 Sep; 35(3):394-400. PubMed ID: 33458663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension.
    Nickel N; Kempf T; Tapken H; Tongers J; Laenger F; Lehmann U; Golpon H; Olsson K; Wilkins MR; Gibbs JS; Hoeper MM; Wollert KC
    Am J Respir Crit Care Med; 2008 Sep; 178(5):534-41. PubMed ID: 18565955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
    Qian J; Li M; Zhang X; Wang Q; Zhao J; Tian Z; Wei W; Zuo X; Zhang M; Zhu P; Ye S; Zhang W; Zheng Y; Qi W; Li Y; Zhang Z; Ding F; Gu J; Liu Y; Wang Y; Zeng X;
    Eur Respir J; 2019 Feb; 53(2):. PubMed ID: 30635295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension.
    Geenen LW; Baggen VJM; Kauling RM; Koudstaal T; Boomars KA; Boersma E; Roos-Hesselink JW; van den Bosch AE
    Heart; 2020 Mar; 106(6):467-473. PubMed ID: 31492701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic values of GDF-15 in comparison with NT-proBNP in patients with normotensive acute pulmonary embolism.
    Duran L; Kayhan S; Guzel A; Ince M; Kati C; Akdemir HU; Yavuz Y; Zengin H; Okuyucu A; Murat N
    Clin Lab; 2014; 60(8):1365-71. PubMed ID: 25185423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.
    Guo L; Li M; Chen Y; Wang Q; Tian Z; Pan S; Zeng X; Ye S
    Arthritis Rheumatol; 2015 Sep; 67(9):2394-402. PubMed ID: 26018988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus Erythematosus.
    Xu WD; Huang Q; Yang C; Li R; Huang AF
    Front Immunol; 2022; 13():926373. PubMed ID: 35911685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors of systemic lupus erythematosus-associated pulmonary arterial hypertension: A PRISMA-compliant systematic review and meta-analysis.
    Qian J; Wang Y; Huang C; Yang X; Zhao J; Wang Q; Tian Z; Li M; Zeng X
    Autoimmun Rev; 2016 Mar; 15(3):250-7. PubMed ID: 26640159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.